Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
LOS ANGELES Gardner Geary Coll has been chosen to help launch pharmaceutical company BioGentec’s flagship allergy product, Allertin.
The San Francisco shop won the account after a review that included Eicoff Direct-Health in Chicago, the client said.
Annual billings have not been determined. BioGentec is expected to spend $4-5 million for a test-market launch in July. A broader introduction is scheduled for the first quarter of 2004.
GGC is developing a brand identity program, marketing plans and an integrated communications campaign for the Irvine, Calif.,
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in